Epithalon (Epitalon) Research Overview: Telomeres, Aging, and Longevity
Research Use Only. This article is for scientific and educational reference only. All products are sold for research purposes and are not intended for human or animal consumption.
Overview
Epithalon (also spelled Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from Epithalamin, a natural polypeptide extracted from the pineal gland of cattle. It was developed by the St. Petersburg Institute of Bioregulation and Gerontology, where it has been the subject of over 40 years of research into aging, telomere biology, and longevity.
Mechanism of Action
Epithalon's primary research interest stems from its apparent ability to activate telomerase, the enzyme responsible for maintaining telomere length.
Telomere biology: Telomeres are protective caps at the ends of chromosomes that shorten with each cell division. When telomeres reach a critically short length, cells enter senescence or apoptosis. Telomere shortening is considered a fundamental mechanism of cellular aging.
Telomerase activation: Research by Khavinson et al. demonstrated that Epithalon stimulates telomerase activity in human somatic cells, leading to telomere elongation. This is significant because most somatic cells have low or absent telomerase activity.
Pineal gland regulation: Epithalon is derived from Epithalamin, which regulates pineal gland function. Research has shown that Epithalon normalizes melatonin secretion patterns in aged animals.
Antioxidant effects: Studies have demonstrated that Epithalon reduces lipid peroxidation and increases antioxidant enzyme activity (superoxide dismutase, catalase).
Key Research Findings
Telomere elongation in human cells: A landmark study published in the Bulletin of Experimental Biology and Medicine demonstrated that Epithalon treatment of human fetal fibroblasts increased telomerase activity and extended the Hayflick limit (maximum number of cell divisions) from approximately 34 passages to 44 passages.
Lifespan extension in animal models: Multiple studies in rodent models have reported lifespan extension with Epithalon treatment. A study in Drosophila melanogaster showed a 16% increase in mean lifespan. Studies in rats showed reduced incidence of spontaneous tumors and extended maximum lifespan.
Cancer research: Epithalon has been studied for potential anti-tumor effects. Research in mammary tumor models showed reduced tumor incidence and delayed tumor development.
Circadian rhythm normalization: Studies in aged rats demonstrated that Epithalon normalized disrupted circadian rhythms and melatonin secretion patterns.
Clinical Research
The St. Petersburg Institute conducted longitudinal studies in elderly humans (65-80 years) receiving Epithalon over multiple years. Reported findings included:
- Improved cardiovascular function markers - Normalized melatonin secretion - Improved sleep quality - Reduced incidence of respiratory infections - Improved psychological well-being scores
These studies were conducted in Russia and have not been replicated in Western peer-reviewed clinical trials, which represents a limitation of the current evidence base.
Pharmacokinetics
| Parameter | Value | |-----------|-------| | Molecular weight | 390.35 Da | | Route | Subcutaneous or intranasal | | Half-life | Short (minutes) | | Bioavailability | Higher via subcutaneous vs. oral |
Summary
Epithalon represents one of the most extensively studied peptides in longevity and telomere research, with over four decades of preclinical and clinical investigation from the St. Petersburg Institute. Its telomerase-activating properties and lifespan extension data in animal models make it a unique research tool in aging biology.
See Also: MOTS-c Research Overview: Mitochondrial Peptide and Metabolic Health | NAD+ Research Overview | Peptide Research Glossary: Key Terms and Definitions
Was this article helpful?
Click a star to rate